Valuation: Oxford BioDynamics Plc

Market Cap 17.26M 19.27M 15.87M 14.38M 26.88M 1.83B 27.39M 189M 75.98M 962M 72.31M 70.77M 3.03B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 20.89M 23.32M 19.21M 17.41M 32.54M 2.21B 33.15M 229M 91.98M 1.16B 87.53M 85.67M 3.67B EV / Sales 2026 *
11x
EV / Sales 2027 * -
Free-Float
90.64%
Yield 2026 *
-
Yield 2027 * -
1 day+1.90%
1 week-6.52%
Current month-11.16%
1 month-11.16%
3 months-6.52%
6 months-47.56%
Current year-50.00%
1 week 0.1
Extreme 0.105
0.12
1 month 0.09
Extreme 0.09
0.12
Current year 0.08
Extreme 0.08
0.34
1 year 0.08
Extreme 0.08
0.34
3 years 0.08
Extreme 0.08
38.8
5 years 0.08
Extreme 0.08
52
10 years 0.08
Extreme 0.08
278.82
Manager TitleAgeSince
Chief Executive Officer - 30/06/2026
Chief Tech/Sci/R&D Officer 64 08/06/2007
Director of Finance/CFO - 15/09/2017
Director TitleAgeSince
Director/Board Member 64 08/06/2007
Director/Board Member - 15/09/2017
Director/Board Member 65 05/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
10/11/25 Free

Founder

15,000,000 0.7663%
10/11/25 Free

Executive/Senior Manager

15,000,000 0.7663%
10/11/25 Free

Chief Operating Officer

15,000,000 0.7663%
Change 5-day change 1-year change 3-year change Capi.($)
+1.90%-6.52%-66.30%-99.68% 19.27M
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +1.75%+4.66%+35.30%+64.86% 426.19B
Weighted average by Cap. +1.19%+6.60%+50.88%+98.31%

Financials

2026 *2027 *
Net sales 1.89M 2.11M 1.74M 1.58M 2.95M 200M 3M 20.74M 8.33M 105M 7.92M 7.76M 333M -
Net income - -
Net Debt 3.63M 4.06M 3.34M 3.03M 5.66M 385M 5.77M 39.85M 16M 203M 15.22M 14.9M 639M -
Projected Income Statement - Annual - Oxford BioDynamics Plc
Logo Oxford BioDynamics Plc
Oxford BioDynamics Plc is a United Kingdom-based biotechnology company, advancing personalized healthcare by developing and commercializing precision clinical diagnostic tests for life-changing diseases. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch PSE, Specimen Submission Kit, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The Specimen Submission Kit is used for collecting samples from any location. The EpiSwitch platform offers reproducibly translating three-dimensional (3D) genome regulation for clinical applications. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.
Employees
-
Date Price Change Volume
30/10/26 GBX 0.1070 +1.90% 14,706,011
29/10/26 GBX 0.1050 -4.55% 27,235,354
28/10/26 GBX 0.1100 -5.98% 15,927,010
27/10/26 GBX 0.1170 0.00% 27,056,478
26/10/26 GBX 0.1170 +1.74% 11,518,328
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001070GBP
Average target price
0.003000GBP
Spread / Average Target
+180.37%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Oxford BioDynamics Plc